TSS
BIO icon

Two Sigma Securities’s Bio-Rad Laboratories Class A BIO Stock Holding History

Two Sigma Securities’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,199
Closed -$363K – 1679
2025
Q4 		$363K Buy
+1,199
New +$374K 0.05% 536
2024
Q2 		– Sell
-767
Closed -$265K – 2990
2024
Q1 		$265K Buy
+767
New +$252K ﹤0.01% 2071
2023
Q4 		– Sell
-931
Closed -$292K – 3032
2023
Q3 		$334K Buy
+931
New +$359K ﹤0.01% 1859
2022
Q4 		– Sell
-2,205
Closed -$920K – 2594
2022
Q3 		$920K Buy
+2,205
New +$1.1M 0.03% 685

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Securities's BIO Position: Q1 2026 in Review

Two Sigma Securities sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 1,199 shares — an estimated $363K sold.

Two Sigma Securities first reported a position in BIO in Q3 2022 and held it in 4 quarters. The position peaked at $920K in Q3 2022. 394 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Two Sigma Securities reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 1,199 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $363K.
  • Two Sigma Securities first reported a position in Bio-Rad Laboratories Class A in Q3 2022 and held it in 4 quarters.
  • Two Sigma Securities's Bio-Rad Laboratories Class A position peaked at $920K in Q3 2022.
  • 394 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.